ISSN: 1172-7047
Journal Home
Journal Guideline
CNS Drugs Q1 Unclaimed
CNS Drugs is a journal indexed in SJR in Neurology (clinical) and Psychiatry and Mental Health with an H index of 129. It has a price of 3190 €. It has an SJR impact factor of 1,616 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,616.
CNS Drugs focuses its scope in these topics and keywords: comprehensive, review, receptorsefficacy, properties, peptide, patients, pathophysiology, orthostatic, neurogenic, reviewmanagement, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3190 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,616
SJR Impact factor129
H Index74
Total Docs (Last Year)264
Total Docs (3 years)5881
Total Refs1631
Total Cites (3 years)253
Citable Docs (3 years)6.14
Cites/Doc (2 years)79.47
Ref/DocOther journals with similar parameters
The Lancet Neurology Q1
Neuro-Oncology Q1
Nature Reviews Neurology Q1
JAMA Neurology Q1
Molecular Neurodegeneration Q1
Compare this journals
Aims and Scope
Best articles by citations
A Multi-Center, Open-Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females
View moreClinical Implications of CNS Penetration of Antiretroviral Drugs
View moreUse of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions
View moreNeuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression
View moreFOREWORD
View moreComment on: "Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence"
View moreVenous Thromboembolism in Recipients of Antipsychotics
View moreStimulation of the Nervous System for the Management of Seizures
View moreDisease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis
View moreAmyotrophic Lateral Sclerosis
View moreEfficacy and Safety of Intravenous Valproate for Status Epilepticus: A Systematic Review
View moreTreatment of Epilepsy in Women of Childbearing Potential
View moreEslicarbazepine Acetate
View moreDiscontinuation Syndrome Associated with Paroxetine in Depressed Patients
View moreEmergency and Critical Care Management of Acute Ischaemic Stroke
View moreTreatment of Partial Seizures in Childhood
View moreNew Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability
View morePeginterferon Beta-1a: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
View moreManagement of Psychiatric Comorbidity in Anorexia Nervosa and??Bulimia Nervosa
View morePharmacotherapy for Cannabis Dependence
View moreMood Stabilizers and Antipsychotics for Acute Mania: A Systematic Review and Meta-Analysis of Combination/Augmentation Therapy Versus Monotherapy
View morePregabalin in the Treatment of Generalised Anxiety Disorder
View moreWeight Regain after Discontinuation of Topiramate Treatment in Patients with Migraine: a Prospective Observational Study
View morePrevention Studies in Alzheimer's Disease: Progress Towards the Development of New Therapeutics
View more
Comments